Group praises US strides in tobacco control

Published January 20, 2011

Group praises US strides in tobacco control

Read more on AlertNet

Phase 2 Clinical Trial Begins For Liver Transplant Patients Receiving Experimental Drug To Prevent Hepatitis C Infection
Following a successful Phase 1 study for safety, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) have announced the beginning of a Phase 2 clinical trial testing the ability of a human monoclonal antibody they developed to prevent hepatitis C virus (HCV) infection of a donor liver in transplant patients. The first patients were enrolled in the study in …
Read more on Medical News Today

EKOS Corporation Receives CE Mark To Treat Massive And Sub-Massive Pulmonary Embolism
EKOS Corporation announced the EKOS EkoSonic® Endovascular System is the first endovascular device approved for the treatment of pulmonary embolism (PE). The EkoSonic® System, which was originally designed and approved to dissolve blood clots in the arms and legs, now has the added indication for treating this major unmet medical need. “There are frustratingly few tools available today to help …
Read more on Medical News Today